Evidence map›Paper›PMID 31998292›Full record

ArticleFrontiers in immunology2019

Conservation of the OmpC Porin Among Typhoidal and Non-Typhoidal

Nuriban Valero-Pacheco, Joshua Blight, Gustavo Aldapa-Vega, Phillip Kemlo, Marisol Pérez-Toledo, Isabel Wong-Baeza, Ayako Kurioka, Christian Perez-Shibayama, Cristina Gil-Cruz, Luvia E Sánchez-Torres and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Frontiers in immunology · 2026
    Article
  3. Outer membrane protein C (OMPC) epitope ofFrontiers in immunology · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 3 countries.

Nuriban Valero-PachecoUnidad de Investigación Médica en Inmunoquímica, Hospital de Especialidades del Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Joshua BlightNuffield Department of Medicine, The Henry Wellcome Building for Molecular Physiology, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Gustavo Aldapa-VegaUnidad de Investigación Médica en Inmunoquímica, Hospital de Especialidades del Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Phillip KemloNuffield Department of Medicine, The Henry Wellcome Building for Molecular Physiology, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Marisol Pérez-ToledoUnidad de Investigación Médica en Inmunoquímica, Hospital de Especialidades del Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Isabel Wong-BaezaDepartamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
Ayako KuriokaPeter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
Christian Perez-ShibayamaInstitute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Cristina Gil-CruzInstitute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Luvia E Sánchez-TorresDepartamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
Rodolfo Pastelin-PalaciosFacultad de Química, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Armando IsibasiUnidad de Investigación Médica en Inmunoquímica, Hospital de Especialidades del Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Arturo Reyes-SandovalNuffield Department of Medicine, The Henry Wellcome Building for Molecular Physiology, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Paul KlenermanPeter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
Constantino López-MacíasUnidad de Investigación Médica en Inmunoquímica, Hospital de Especialidades del Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Hospital de Especialidades · MXInstituto Politécnico Nacional · MXJenner Institute · GBKantonsspital St. Gallen · CHUniversity of Oxford · GBCentro Medico Nacional Siglo XXI · MXMedawar Building for Pathogen Research · GBMexican Social Security Institute · MXUniversidad Nacional Autónoma de México · MX

Funding

Biotechnology and Biological Sciences Research CouncilMedical Research Council 1240480Medical Research Council MR/R005974/1Wellcome Trust 109965/Z/15/ZWellcome Trust WT 091663MAWellcome Trust WT 097395/Z/11/Z
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Amino Acid SequenceBacterial ProteinsConserved SequenceHumansPhylogenyPorinsProtein Conformation, alpha-HelicalSalmonellaSalmonella InfectionsSalmonella typhiSequence AlignmentTyphoid FeverBacterial ProteinsOmpC proteinPorinsimmunogenicitynon-typhoidalOmpCporinSalmonellasalmonellosistyphoidvaccine

Identifiers

PMID31998292
PMCPMC6962181
OpenAlexW2996401476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.